1. Home
  2. ACMR vs DYN Comparison

ACMR vs DYN Comparison

Compare ACMR & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ACM Research Inc.

ACMR

ACM Research Inc.

HOLD

Current Price

$38.90

Market Cap

2.3B

Sector

Technology

ML Signal

HOLD

DYN

Dyne Therapeutics Inc.

HOLD

Current Price

$19.38

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACMR
DYN
Founded
1998
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
1.9B
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
ACMR
DYN
Price
$38.90
$19.38
Analyst Decision
Buy
Strong Buy
Analyst Count
3
16
Target Price
$43.00
$40.25
AVG Volume (30 Days)
1.1M
3.4M
Earning Date
11-05-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
29.16
N/A
EPS
1.72
N/A
Revenue
$880,350,000.00
N/A
Revenue This Year
$18.22
N/A
Revenue Next Year
$16.80
N/A
P/E Ratio
$22.53
N/A
Revenue Growth
20.77
N/A
52 Week Low
$14.65
$6.36
52 Week High
$45.12
$27.59

Technical Indicators

Market Signals
Indicator
ACMR
DYN
Relative Strength Index (RSI) 63.86 47.95
Support Level $32.20 $19.20
Resistance Level $37.85 $20.80
Average True Range (ATR) 1.86 1.49
MACD 0.96 -0.29
Stochastic Oscillator 78.25 20.70

Price Performance

Historical Comparison
ACMR
DYN

About ACMR ACM Research Inc.

ACM Research Inc supplies advanced, innovative capital equipment developed for the world-wide semiconductor industry. Fabricators of advanced integrated circuits, or chips, can use its wet-cleaning and other front-end processing tools in numerous steps to improve product yield, even at increasingly advanced process nodes. It has designed these tools for use in fabricating foundry, logic and memory chips, including dynamic random-access memory, or DRAM, and 3D NAND-flash memory chips. The company also develops, manufactures and sells advanced packaging tools to wafer assembly and packaging customers.

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Share on Social Networks: